Cellebrite DI Ltd.: stock overview

CLBTNASDAQTechnology · Services-Prepackaged Software

Price

$11.53

November 13, 2026Market cap $2.9B

What Ploutos Investor adds for Cellebrite DI

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from 2019
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

Cellebrite DI had revenue of $476M in the fiscal year to December 31, 2025 and net income of $78M, a net margin of 16.5%. Revenue grew by 19.5% a year on average over the last 5 years. At $11.53 the shares trade at a P/E of 36.7, against a median of 18.2 over the last 3 fiscal years. It holds more cash than debt, by $276M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$2.9B
249M shares
P/E
36.7
Today36.7
Median18.2
Revenue, fiscal year
$476M
+19.5% a year over 5 years
Net margin
16.5%
above 81% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2023–2025 fiscal years

+21.0% a year over 2 years

  • 202520-F
    Revenue$476M
  • 202420-F
    Revenue$401M
  • 202320-F
    Revenue$325M

Fiscal years in figures

CLBT's revenue, profit, cash flow and dividend with each year-end price, from 2019 to 2022, 4 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $4.5B
$2.9B
Enterprise value 
$2.6B
P/E 
36.7
EV / EBIT 
39.1
EV / Revenue 
5.5
P/B 3-year median: 15.7
5.9
FCF yield 3-year median: 3.6%
5.6%
Earnings yield 3-year median: -5.0%
2.7%

Profitability

Gross margin 
84.2%
Operating margin 
14.0%
Net margin 3-year median: -24.9%
16.5%
ROIC 
10.8%
ROIC, 5-year average 
12.1%
ROE, fiscal year 
16.2%

Growth

Revenue, yearly change 
+18.6%
EPS, yearly change 
–
FCF, yearly change 
+29.7%
Revenue, average a year 
+19.5%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$276M
Total debt 
$23M
Of which operating leases 
$23M
Net cash 
$276M
Net debt / EBITDA 
-3.5x
Interest cover 
–
Current ratio 
–

Balance sheet of December 31, 2025.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+4.2%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 73).

Gross margin

84.2%

Above 95% of the 293 companies in its industry, and 97% of all.

Operating margin

14.0%

Above 77% of the 462 companies in its industry, and 73% of all.

Net margin

16.5%

Above 81% of the 473 companies in its industry, and 78% of all.

ROE

16.2%

Above 76% of the 398 companies in its industry, and 78% of all.

ROA

8.3%

Above 80% of the 462 companies in its industry, and 84% of all.

Revenue growth

18.6%

Above 76% of the 461 companies in its industry, and 79% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Cellebrite DI Ltd.
Exchange
NASDAQ
Industry (SIC)
7372 · Services-Prepackaged Software
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
249M

Other companies: Technology

The largest companies of the same sector, each with its own page.

The Technology sectorAll companies

The full analysis

What do Cellebrite DI's filings show?

These are Cellebrite DI's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CLBT

Didn't find what you were looking for?

Ask us
What is CLBT's market cap?

Cellebrite DI Ltd.'s market cap is $2.9B, at a price of $11.53 on November 13, 2026 and 249M shares.

What is CLBT's P/E?

CLBT's P/E is 36.7, on earnings per share of $0.31 in the fiscal year to December 31, 2025. The median over the last 3 fiscal years was 18.2.

How much revenue does CLBT have?

Cellebrite DI had revenue of $476M in the fiscal year to December 31, 2025. Over the last 5 years it changed by +19.5% a year on average.

Does CLBT pay a dividend?

No. Cellebrite DI paid no regular dividend over the last 12 months.

Where do the figures come from?

From Cellebrite DI Ltd.'s SEC filings (its annual report on 20-F) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.